日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An automated plasma-based proteotyping immunoassay for APOE ε4 zygosity classification in Alzheimer's disease

一种基于血浆的自动化蛋白质组学免疫分析方法,用于阿尔茨海默病中APOE ε4基因型分类

Levin, Scott; Engel, Brian; Carlson, Corey; Hinson, Jeremiah; Holland, Mark; Figdore, Dan; Lim, Hyun Kook; Tiers, Laurent; Bhatt, Kinal; Schlichtmann, Ben; Hoffmann, Katie; Bae, Ye Eun; Szabo, Miklos; Lehmann, Sylvain; Um, Yoo Hyun; Algeciras-Schimnich, Alicia

False positive plasma p-tau217 results associated with heterophilic antibody interference: A potential clinical pitfall

与嗜异性抗体干扰相关的血浆p-tau217假阳性结果:潜在的临床陷阱

Algeciras-Schimnich, Alicia; Theobald, J Paul; Figdore, Daniel J; Ashrafzadeh Kian, Susan; Bornhorst, Joshua A

Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratios

阿尔茨海默病血液生物标志物稳定性的差异:对tau蛋白/淀粉样蛋白比率应用的影响

Figdore, Daniel J; Schuder, Bethany J; Ashrafzadeh-Kian, Susan; Gronquist, Tina; Bornhorst, Joshua A; Algeciras-Schimnich, Alicia

Diagnostic performance of plasma p-tau217 and Aβ42/40 biomarkers in the outpatient memory clinic

血浆p-tau217和Aβ42/40生物标志物在门诊记忆诊所的诊断性能

Piura, Yoav D; Figdore, Daniel J; Lachner, Christian; Bornhorst, Joshua; Algeciras-Schimnich, Alicia; Graff-Radford, Neill R; Day, Gregory S

Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma P-Tau217 Concentrations

慢性肾脏病对血浆P-Tau217浓度影响的定量评估

Bornhorst, Joshua A; Lundgreen, Carly S; Weigand, Stephen D; Figdore, Daniel J; Wiste, Heather; Griswold, Michael; Vemuri, Prashanthi; Graff-Radford, Jonathan; Knopman, David S; Cogswell, Petrice; Jack, Clifford R; Petersen, Ronald C; Algeciras-Schimnich, Alicia

Combating Genetic Heterogeneity for Polygenic Prediction of Susceptibility to Brain β-Amyloid Deposition: Beyond APOE

克服遗传异质性,实现对脑β-淀粉样蛋白沉积易感性的多基因预测:超越APOE

Ramanan, Vijay K; Heckman, Michael G; Hofrenning, Ekaterina I; Przybelski, Scott A; Graff-Radford, Jonathan; Lowe, Val J; Machulda, Mary M; Murray, Melissa E; Algeciras-Schimnich, Alicia; Figdore, Daniel J; Bennett, David A; Knopman, David S; Jack, Clifford R Jr; Petersen, Ronald C; Ross, Owen A; Vemuri, Prashanthi

Association of plasma biomarkers of Alzheimer's pathology and neurodegeneration with gait performance in older adults

老年人血浆中阿尔茨海默病理和神经退行性变生物标志物与步态表现的关联

Ali, Farwa; Syrjanen, Jeremy A; Figdore, Dan J; Kremers, Walter K; Mielke, Michelle M; Jack, Clifford R; Knopman, David S; Vemuri, Prashanthi; Graff-Radford, Jonathan; Windham, B Gwen; Barnard, Leland R; Petersen, Ronald C; Algeciras-Schimnich, Alicia

Performance of the Lumipulse plasma p‐tau217 assay to assess eligibility for amyloid‐lowering therapies

Lumipulse血浆p-tau217检测在评估患者是否适合接受淀粉样蛋白降低疗法方面的性能

Ciampa, Claire J; Parent, Jourdan H; Harrison, Theresa M; Fain, Rebekah M; Betts, Matthew J; Maass, Anne; Winer, Joseph R; Baker, Suzanne L; Janabi, Mustafa; Furman, Daniella J; D'Esposito, Mark; Jagust, William J; Berry, Anne S; Algeciras‐Schimnich, Alicia; Ashrafzadeh‐Kian, Susan; Bornhorst, Joshua A; Figdore, Daniel; Burkett, Brian J; Cogswell, Petrice M; Johnson, Derek R; McCarter, Stuart J; Graff‐Radford, Jonathan; Petersen, Ronald; Ramanan, Vijay K

Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays

利用血浆p-tau217免疫测定法优化脑淀粉样蛋白状态临床解读的临界值

Figdore, Daniel J; Griswold, Michael; Bornhorst, Joshua A; Graff-Radford, Jonathan; Ramanan, Vijay K; Vemuri, Prashanthi; Lowe, Val J; Knopman, David S; Jack, Clifford R Jr; Petersen, Ronald C; Algeciras-Schimnich, Alicia

Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals

比较血浆生物标志物和淀粉样蛋白PET在预测认知功能正常个体记忆力衰退方面的表现

Jack, Clifford R Jr; Wiste, Heather J; Algeciras-Schimnich, Alicia; Weigand, Stephen D; Figdore, Dan J; Lowe, Val J; Vemuri, Prashanthi; Graff-Radford, Jonathan; Ramanan, Vijay K; Knopman, David S; Mielke, Michelle M; Machulda, Mary M; Fields, Julie; Schwarz, Christopher G; Cogswell, Petrice M; Senjem, Matthew L; Therneau, Terry M; Petersen, Ronald C